Hepatic - Colorectal Metastasis - Pipeline Insight, 2018 Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 22, 2018--The “Hepatic - Colorectal Metastasis - Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.
‘Hepatic - Colorectal Metastasis - Pipeline Insight, 2018’ report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatic - Colorectal Metastasis development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline Products covered across the following Developmental Stages:Clinical Non-clinical Inactive: Discontinued and/or Dormant
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
Scope of the report:The report provides a snapshot of the pipeline development for the Hepatic - Colorectal Metastasis The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Hepatic - Colorectal Metastasis The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Hepatic - Colorectal Metastasis The report also covers the dormant and discontinued pipeline projects related to the Hepatic - Colorectal Metastasis
Key Topics Covered:
1. Report Introduction
2. Hepatic - Colorectal Metastasis Overview
3. Pipeline TherapeuticsAn Overview of Pipeline Products for Hepatic - Colorectal Metastasis
4. Comparative Analysis
5. Products in Clinical StageProduct Description Research and Development Product Development Activities
6. Products in Pre-Clinical and Discovery StageProduct Description Research and Development Product Development Activities
7. Therapeutic AssessmentAssessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type
8. Inactive ProductsProduct Description Research and Development Product Development Activities
Companies MentionedAlfact Innovation Cellular Biomedicine Group Inc Delcath Systems Inc Gradalis Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/kvkw4c/hepatic?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180822005597/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Colon Cancer Drugs
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/22/2018 02:17 PM/DISC: 08/22/2018 02:17 PM